FINT
FINAL DECISION TRANSACTION PROCESSED BY IB
01/31/2023
Back to search
Official data from USPTO
ALMOTREX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
01/31/2023
Trademark type
Combined
Nice classes
5
Filing date
09/06/2007
Registration date
10/28/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/29/2015
Last transaction
04/15/2019
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
ES
Examiner
VENGROFF, MARILYN
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ALMIRALL, S.A.
Almirall AG
Representatives
E. BLUM & CO. AG Patent- und Markenanwälte VSP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalspreparations for the treatment of disorders of the central nervous systemincluding migraine
Publications
History of USPTO decisions and trademark events.
38 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
12/28/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
12/28/2022
BDFU
BIRTH/DEATH MERGER PROCESSED BY USPTO
12/16/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/28/2022
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/27/2019
CHLD
CHANGE OF OWNER RECEIVED FROM IB
05/11/2019
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
03/24/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/23/2016
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/04/2016
INPC
INVALIDATION PROCESSED
04/04/2016
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/29/2016
GPNX
NOTIFICATION PROCESSED BY IB
07/11/2015
C71T
CANCELLED SECTION 71
05/29/2015
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/30/2011
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/18/2009
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
03/20/2009
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/06/2009
FIMP
FINAL DISPOSITION PROCESSED
02/06/2009
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/28/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
10/28/2008
PUBO
PUBLISHED FOR OPPOSITION
08/12/2008
NPUB
NOTICE OF PUBLICATION
07/23/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/09/2008
ALIE
ASSIGNED TO LIE
07/09/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/09/2008
CNEA
EXAMINERS AMENDMENT MAILED
06/11/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
06/10/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/10/2008
RFNT
REFUSAL PROCESSED BY IB
01/04/2008
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/14/2007
RFRR
REFUSAL PROCESSED BY MPU
12/14/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/14/2007
CNRT
NON-FINAL ACTION WRITTEN
12/13/2007
DOCK
ASSIGNED TO EXAMINER
12/12/2007
NWAP
NEW APPLICATION ENTERED
10/22/2007
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
10/19/2007
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
10/18/2007
Continuous trademark protection
Get notified about every new filing that threatens ALMOTREX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.